Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
Michelle Obama’s book details how the media’s fixation on her arms was used to ‘otherize’ her
4/11/2025
Donna Jean Godchaux supplied steel and soul to the Grateful Dead in their prime
4/11/2025
A definitive list of what’s cool (and what’s not cool) | Letters
4/11/2025
Let’s have a level playing field on publicising the ethnicity of suspects | Letter
4/11/2025
Ashford’s ghost terminal could be brought back to life by Richard Branson | Letters
4/11/2025
Tax rises shouldn’t be taxing for Reeves | Brief letters
4/11/2025